- within Technology topic(s)
- with readers working within the Pharmaceuticals & BioTech industries
- within Transport, Insolvency/Bankruptcy/Re-Structuring and Strategy topic(s)
We are delighted to share the third edition of the William Fry Technology Report.
69% of larger Irish organisations remain actively concerned about extracting measurable return from the AI solutions they have already procured, and only 11% report a positive return to date.
The issue is compounded by first-generation AI contracts that transferred risk to the buyer while leaving the return question undefined, and which many organisations are now revisiting as the EU AI Act, DORA, NIS 2, and the Data Act introduce requirements those contracts do not adequately address.
Dr. Barry Scannell, Partner in our Technology group, examines what renegotiation looks like in practice, the five principal barriers to scaling AI identified in this year’s survey, and how the economics of AI contracts are beginning to shift in favour of buyers prepared to negotiate.
Explore ‘Return on Investment: The Key Commercial Question‘below, or read our full report here.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
[View Source]